Press releases

6 Dec 2012

New Oral Drug Candidate for African Sleeping Sickness

Press releases

30 Nov 2012

DNDi Applauds Call for Scale-Up of Pediatric HIV Treatment in US PEPFAR Blueprint for an AIDS-Free Generation

Press releases

13 Nov 2012

DNDi-MMV press release: Open Access Initiative Reveals Drug Hits for Deadly Neglected Tropical Diseases

Press releases

12 Nov 2012

USD 3 Million Awarded to Find Biomarkers for Potential Test of Cure for Chagas Disease

Press releases

8 Nov 2012

International Medical Conference to Assess Progress and Shortcomings of Global Health Revolution for Neglected Patients

Press releases

3 Oct 2012

Cipla-DNDi Press Release: WHO Prequalifies A New Artemisinin-Based Combination Treatment (ACT) for Malaria. Artesunate-Mefloquine Fixed-Dose Combination (ASMQ FDC) to be rolled out throughout Asia

Press releases

23 Sep 2012

Brazilian Ministry of Health, Fiocruz and DNDi Latin America to Fight Neglected Diseases through Research and Development Partnership

Press releases

20 Jul 2012

DNDi and Cipla to Develop 4-in-1 Paediatric Antiretroviral Drug Combination – New formulation to fill the deadly gap in appropriate HIV medicines

Press releases

29 Jun 2012

DNDi Appoints New R&D Director

Press releases

21 Jun 2012

University of Dundee awards Bernard Pécoul

Press releases

12 Jun 2012

Astellas and DNDi to Collaborate on New Drug Discovery Research for the Treatment of Neglected Tropical Diseases

Press releases

21 May 2012

Sustainable R&D Framework Needed to Address Essential Health Needs of Developing Countries

Press releases

24 Apr 2012

Cipla and DNDi announce the forthcoming launch of Artesunate + Mefloquine fixed-dose combination for P. falciparum malaria

Press releases

12 Apr 2012

AstraZeneca and DNDi to Collaborate on Drug Screening for Neglected Tropical Diseases

Press releases

12 Mar 2012

DNDi Secures EUR 2 Million Strategic Translation Award from Wellcome Trust to Develop a New Drug against Chagas Disease

Press releases

12 Mar 2012

DNDi Launches Phase I In-Human Clinical Trial for Promising Oral Drug for Sleeping Sickness